Immunovant, Inc. (IMVT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:17PM EDT. Market open.
| Previous close | 28.32 |
| Open | 28.27 |
| Bid | 27.44 x 100 |
| Ask | 27.54 x 100 |
| Day's range | 27.33 - 28.64 |
| 52-week range | 15.11 - 45.58 |
| Volume | |
| Avg. volume | 1,160,667 |
| Market cap | 3.999B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.81 |
| Earnings date | 13 May 2024 - 27 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 50.86 |
ZacksWhat Makes Immunovant (IMVT) a New Buy Stock
Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investor's Business DailyArgenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
Biotech stocks Argenx and Immunovant surged Thursday — and Tourmaline fell — on a rival's lackluster muscle disease drug study.
Insider Monkey11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]
© 2024 Yahoo. All rights reserved.